Ahk Cu Peptide
AHK-Cu is a synthetic copper-binding tripeptide studied in preclinical research, not an approved therapeutic in Australia. The main biological evidence comes from 2007 follicle work, not human clinical trials, so Australian buyers should treat it as a laboratory compound first and a treatment claim never.
That distinction matters